Misfolded proteins in Alzheimer's disease and type II diabetes.

No abstract is available for this paper.

• Publication year

  2012

• Venue

  Chemical Society Reviews

• Publication date

  2012-01-04

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1039/c1cs15112fPMID 21818468PMCID PMC3210870
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The heterogeneous nature of Cu2+ interactions with Alzheimer's amyloid-β peptide.

  2011cited by this paper
• 2011 Alzheimer's disease facts and figures

  2011cited by this paper
• Interactions of Zn(II) and Cu(II) ions with Alzheimer's amyloid-beta peptide. Metal ion binding, contribution to fibrillization and toxicity.

  2011cited by this paper
• Myricetin: A Naturally Occurring Regulator of Metal‐Induced Amyloid‐β Aggregation and Neurotoxicity

  2011cited by this paper
• Dynamic action of neurometals at the synapse.

  2011cited by this paper
• A two-site mechanism for the inhibition of IAPP amyloidogenesis by zinc.

  2011cited by this paper
• Biphasic effects of insulin on islet amyloid polypeptide membrane disruption.

  2011cited by this paper
• Deaths: final data for 2008.

  2011cited by this paper
• Insight into Amyloid Structure Using Chemical Probes

  2011cited by this paper
• Synthesis and characterization of IMPY derivatives that regulate metal-induced amyloid-β aggregation.

  2011cited by this paper
• Regulated intramembrane proteolysis – lessons from amyloid precursor protein processing

  2011cited by this paper
• N-Aryl-substituted 3-(β-D-glucopyranosyloxy)-2-methyl-4(1H)-pyridinones as agents for Alzheimer's therapy

  2011cited by this paper
• Deaths: preliminary data for 2009.

  2011cited by this paper
• Role of metal dyshomeostasis in Alzheimer's disease.

  2011cited by this paper
• Affinity of Cu+ for the copper-binding domain of the amyloid-β peptide of Alzheimer's disease.

  2011cited by this paper
• Structural evolution of Iowa mutant β-amyloid fibrils from polymorphic to homogeneous states under repeated seeded growth.

  2011cited by this paper
• Recent Development of Bifunctional Small Molecules to Study Metal-Amyloid-β Species in Alzheimer's Disease

  2010cited by this paper
• Substoichiometric Levels of Cu2+ Ions Accelerate the Kinetics of Fiber Formation and Promote Cell Toxicity of Amyloid-β from Alzheimer Disease*

  2010cited by this paper
• Design of small molecules that target metal-Aβ species and regulate metal-induced Aβ aggregation and neurotoxicity

  2010cited by this paper
• Polymorphism in Alzheimer Aβ Amyloid Organization Reflects Conformational Selection in a Rugged Energy Landscape

  2010cited by this paper
• Copper-induced cytotoxicity: reactive oxygen species or islet amyloid polypeptide oligomer formation.

  2010cited by this paper
• Two Functions, One Molecule: A Metal‐Binding and a Targeting Moiety to Combat Alzheimer's Disease

  2010cited by this paper
• Supplementary Material (ESI) for Chemical Communications This journal is (c) The Royal Society of Chemistry 2010 Cyclen-Hybrid Compound Captures Copper to Protect INS-1 Cells from Islet Amyloid Polypeptide Cytotoxicity by Inhibiting and Lysing Effects

  2010cited by this paper
• Solution Structure of Proinsulin

  2010cited by this paper
• Selection for nonamyloidogenic mutants of islet amyloid polypeptide (IAPP) identifies an extended region for amyloidogenicity.

  2010cited by this paper
• Proinsulin levels in patients with pancreatic diabetes are associated with functional changes in insulin secretion rather than pancreatic beta-cell area.

  2010cited by this paper
• In vitro studies of 3-hydroxy-4-pyridinones and their glycosylated derivatives as potential agents for Alzheimer's disease.

  2010cited by this paper
• How does diabetes accelerate Alzheimer disease pathology?

  2010cited by this paper
• Novel drug targets based on metallobiology of Alzheimer's disease

  2010cited by this paper
• Cu(II) cyclen cleavage agent for human islet amyloid peptide.

  2010cited by this paper
• Amyloidogenic protein-membrane interactions: mechanistic insight from model systems.

  2010cited by this paper
• Role of zinc in human islet amyloid polypeptide aggregation.

  2010cited by this paper
• Minding metals: tailoring multifunctional chelating agents for neurodegenerative disease.

  2010cited by this paper
• Iron-export ferroxidase activity of β-amyloid precursor protein is inhibited by zinc in Alzheimer's disease.

  2010cited by this paper
• Insulin is a kinetic but not a thermodynamic inhibitor of amylin aggregation

  2009cited by this paper
• A Prochelator Activated by Hydrogen Peroxide Prevents Metal‐Induced Amyloid β Aggregation

  2009cited by this paper
• Effects of cyclen and cyclam on zinc(II)- and copper(II)-induced amyloid beta-peptide aggregation and neurotoxicity.

  2009cited by this paper
• The chemistry of Alzheimer's disease.

  2009cited by this paper
• Bioinorganic chemistry of copper and zinc ions coordinated to amyloid-beta peptide.

  2009cited by this paper
• Design, selection, and characterization of thioflavin-based intercalation compounds with metal chelating properties for application in Alzheimer's disease.

  2009cited by this paper
• Pleomorphic copper coordination by Alzheimer's disease amyloid-beta peptide.

  2009cited by this paper
• Residual structure in islet amyloid polypeptide mediates its interactions with soluble insulin.

  2009cited by this paper
• Small molecule modulators of copper-induced Abeta aggregation.

  2009cited by this paper
• Atomic structures of IAPP (amylin) fusions suggest a mechanism for fibrillation and the role of insulin in the process

  2009cited by this paper
• Chelation therapy for neurodegenerative diseases

  2009cited by this paper
• Medicinal inorganic chemistry approaches to passivation and removal of aberrant metal ions in disease.

  2009cited by this paper
• Copper and Zinc Binding to Amyloid‐β: Coordination, Dynamics, Aggregation, Reactivity and Metal‐Ion Transfer

  2009cited by this paper
• Alzheimer's disease: from pathology to therapeutic approaches.

  2009cited by this paper
• Abeta-mediated ROS production by Cu ions: structural insights, mechanisms and relevance to Alzheimer's disease.

  2009cited by this paper
• Alzheimer's disease, metal ions and metal homeostatic therapy.

  2009cited by this paper
• Alanine-2 carbonyl is an oxygen ligand in Cu2+ coordination of Alzheimer's disease amyloid-beta peptide--relevance to N-terminally truncated forms.

  2009cited by this paper
• Potential roles of abundant extracellular chaperones in the control of amyloid formation and toxicity.

  2008cited by this paper
• Interaction of membrane‐bound islet amyloid polypeptide with soluble and crystalline insulin

  2008cited by this paper
• A single mutation in the nonamyloidogenic region of islet amyloid polypeptide greatly reduces toxicity.

  2008cited by this paper
• Preparation and study of new poly-8-hydroxyquinoline chelators for an anti-Alzheimer strategy.

  2008cited by this paper
• Copper(II) inhibits the formation of amylin amyloid in vitro.

  2008cited by this paper
• Zinc-amyloid beta interactions on a millisecond time-scale stabilize non-fibrillar Alzheimer-related species.

  2008cited by this paper
• Structures of rat and human islet amyloid polypeptide IAPP(1-19) in micelles by NMR spectroscopy.

  2008cited by this paper
• EGCG redirects amyloidogenic polypeptides into unstructured, off-pathway oligomers

  2008cited by this paper
• Structural studies of copper(I) complexes of amyloid-beta peptide fragments: formation of two-coordinate bis(histidine) complexes.

  2008cited by this paper
• Sequestration of Copper from β-Amyloid Promotes Selective Lysis by Cyclen-Hybrid Cleavage Agents*

  2008cited by this paper
• Membrane damage by human islet amyloid polypeptide through fibril growth at the membrane

  2008cited by this paper
• Therapeutics for Alzheimer’s disease based on the metal hypothesis

  2008cited by this paper
• Evidence of fibril-like β-sheet structures in a neurotoxic amyloid intermediate of Alzheimer's β-amyloid

  2007cited by this paper
• Diabetes in Clinical Practice: Questions and Answers from Case Studies

  2007cited by this paper
• Amyloid peptides and proteins in review.

  2007cited by this paper
• Soluble protein oligomers in neurodegeneration: lessons from the Alzheimer's amyloid β-peptide

  2007cited by this paper
• Small Molecule Inhibitors of Aggregation Indicate That Amyloid β Oligomerization and Fibrillization Pathways Are Independent and Distinct*

  2007cited by this paper
• On the structural definition of amyloid fibrils and other polypeptide aggregates

  2007cited by this paper
• Molecular mapping of the recognition interface between the islet amyloid polypeptide and insulin.

  2006cited by this paper
• Copper homeostasis and neurodegenerative disorders (Alzheimer's, prion, and Parkinson's diseases and amyotrophic lateral sclerosis).

  2006cited by this paper
• Pancreatic signals controlling food intake; insulin, glucagon and amylin

  2006cited by this paper
• Protein misfolding, functional amyloid, and human disease.

  2006cited by this paper
• NMR reveals anomalous copper(II) binding to the amyloid Abeta peptide of Alzheimer's disease.

  2006cited by this paper
• The role of His-18 in amyloid formation by human islet amyloid polypeptide.

  2005cited by this paper
• Metal-binding properties of the peptide APP170-188: a model of the ZnII-binding site of amyloid precursor protein (APP).

  2005cited by this paper
• On the nucleation of amyloid beta-protein monomer folding.

  2005cited by this paper
• On the nucleation of amyloid β‐protein monomer folding

  2005cited by this paper
• The parallel superpleated beta-structure as a model for amyloid fibrils of human amylin.

  2005cited by this paper
• The neurobiology of zinc in health and disease

  2005cited by this paper
• Zinc, the Pancreas, and Diabetes: Insights from Rodent Studies and Future Directions

  2005cited by this paper
• Global prevalence of diabetes: estimates for the year 2000 and projections for 2030.

  2004cited by this paper
• Preliminary studies of a novel bifunctional metal chelator targeting Alzheimer's amyloidogenesis.

  2004cited by this paper
• The mechanism of insulin action on islet amyloid polypeptide fiber formation.

  2004cited by this paper
• Neurodegenerative diseases and oxidative stress

  2004cited by this paper
• Pancreatic beta-cell granule peptides form heteromolecular complexes which inhibit islet amyloid polypeptide fibril formation.

  2004cited by this paper
• Increased risk of type 2 diabetes in Alzheimer disease.

  2004cited by this paper
• Protein aggregation and neurodegenerative disease

  2004cited by this paper
• The role of protein stability, solubility, and net charge in amyloid fibril formation

  2003cited by this paper
• Amyloid beta -protein (Abeta) assembly: Abeta 40 and Abeta 42 oligomerize through distinct pathways.

  2003cited by this paper
• Full-length rat amylin forms fibrils following substitution of single residues from human amylin.

  2003cited by this paper
• Unfolding the role of protein misfolding in neurodegenerative diseases

  2003cited by this paper
• Kinetic Studies of Amyloid β-Protein Fibril Assembly

  2002cited by this paper
• Kinetic studies of amyloid beta-protein fibril assembly. Differential effects of alpha-helix stabilization.

  2002cited by this paper
• A structural model for Alzheimer's beta -amyloid fibrils based on experimental constraints from solid state NMR.

  2002cited by this paper
• Islet amyloid: phase partitioning and secondary nucleation are central to the mechanism of fibrillogenesis.

  2002cited by this paper
• Protein misfolding and disease; protein refolding and therapy

  2001cited by this paper
• Islet amyloid and type 2 diabetes mellitus.

  2000cited by this paper
• Extensive islet amyloid formation is induced by development of Type II diabetes mellitus and contributes to its progression: pathogenesis of diabetes in a mouse model

  1999cited by this paper
• A novel assay in vitro of human islet amyloid polypeptide amyloidogenesis and effects of insulin secretory vesicle peptides on amyloid formation.

  1998cited by this paper

• Changing the amyloid nucleation process using small molecules and substrates: a way to build two-dimensional materials.

  2025cites this paper
• Endogenous Aβ and Exogenous Wheat Gluten Nanostructures: Understanding Peptide Self-Assembly in Disease.

  2025cites this paper
• Construction of High-Performance Wash-Free Aβ Probes Based on Amino Group Optimization and Amphiphilic Molecular Engineering Strategies.

  2025cites this paper
• Nano‐Chaperones: Bridging Therapeutics for Amyloid Aggregation in Alzheimer's Disease and Type‐2 Diabetes Mellitus

  2025cites this paper
• Unraveling the unique amyloid-like aggregation behavior of the tumor suppressor p53 mutants in human cancers.

  2025cites this paper
• Progress on Tripterygium wilfordii Hook f. as a treatment option for neurodegenerative diseases

  2024cites this paper
• Globular-shaped Aβ oligomers have diverse mechanisms for promoting Aβ aggregations with the facilitation of fibril elongation.

  2024cites this paper
• Alzheimer's Disease Pathophysiology and Novel Treatment: An Update

  2024cites this paper
• Engineering Core/Ligands Interfacial Anchors of Nanoparticles for Efficiently Inhibiting Both Aβ and Amylin Fibrillization.

  2024cites this paper
• Targeting misfolding and aggregation of the amyloid-β peptide and mutant p53 protein using multifunctional molecules.

  2024cites this paper
• Fluorimetric Detection of Insulin Misfolding by Probes Derived from Functionalized Fluorene Frameworks

  2024cites this paper
• Bifunctional halloysite nanotube-based Ripk1 siRNA delivery system rescues cognitive impairment by targeting amyloid β plaques for clearance and reducing necrotic neurons in Alzheimer’s disease mice

  2024cites this paper
• Navigating the Intersection: Diabetes and Alzheimer's Intertwined Relationship.

  2024cites this paper
• Modelling Alzheimer's Protein Dynamics: A Data-Driven Integration of Stochastic Methods, Machine Learning and Connectome Insights

  2024cites this paper
• Understanding the prion-like behavior of mutant p53 proteins in triple-negative breast cancer pathogenesis: The current therapeutic strategies and future directions

  2024cites this paper
• Nanofibrous Peptide Hydrogels Leveraging Histidine to Modulate pH-Responsive Supramolecular Assembly and Antibody Release.

  2024cites this paper
• Metal-antimicrobial peptides combo: promising weapons to combat bacteria invaders

  2024cites this paper
• Peptide-based nanomaterials and their diverse applications.

  2024cites this paper
• Identifying the Role of Individual Seal IAPP Amino Acids in Inhibiting the Aggregation of Human IAPP.

  2024cites this paper
• SERS-Based Microfluidic Bioscreening Platform for Selective Detection of β-Amyloid Peptides.

  2024cites this paper
• Diagnosis and therapy of Alzheimer's disease: Light-driven heterogeneous redox processes.

  2024cites this paper
• Understanding the structural dynamics of human islet amyloid polypeptide: Advancements in and applications of ion-mobility mass spectrometry.

  2024cites this paper
• Unveiling the Inhibitory Effect of Magnolol in the Aggregation of Human Calcitonin (hCT): A Comprehensive In-Silico Study.

  2024cites this paper
• A facile two-photon red-emission fluorescent marker with a large Stokes shift for in vivo brain imaging of amyloid-beta aggregates

  2024cites this paper
• Glycosylation: mechanisms, biological functions and clinical implications

  2024cites this paper
• Liquid–liquid phase separation in Alzheimer’s disease

  2024cites this paper
• Probing the Molecular Structure and Dynamics of Membrane-Bound Proteins during Misfolding Processes by Sum-Frequency Generation Vibrational Spectroscopy.

  2024cites this paper
• How Can Insulin Resistance Cause Alzheimer’s Disease?

  2023cites this paper
• Single Molecule Protein Segments Sequencing by a Plasmonic Nanopore.

  2023cites this paper
• Gold Nanoclusters Enhance the Efficacy of the Polymer-Based Chaperone in Restoring and Maintaining the Native Conformation of Human Islet Amyloid Polypeptide.

  2023cites this paper
• Intercommunication between metal ions and amyloidogenic peptides or proteins in protein misfolding disorders

  2023cites this paper
• Crosstalk between protein misfolding and endoplasmic reticulum stress during ageing and their role in age-related disorders.

  2023cites this paper
• Recent advances in the modulation of amyloid protein aggregation using the supramolecular host-guest approaches.

  2023cites this paper
• Optochemical control of Cu(I) homeostasis in mammalian cells.

  2023cites this paper
• Molecular modeling of apoE in complexes with Alzheimer’s amyloid-β fibrils from human brain suggests a structural basis for apolipoprotein co-deposition with amyloids

  2023cites this paper
• Aβ Amyloid Fibers Drastically Alter the Topography and Mechanical Properties of Lipid Membranes.

  2023cites this paper
• Re-Arranging the Puzzle between the Amyloid-Beta and Tau Pathology: An APP-Centric Approach

  2023cites this paper
• Recent Advances in the Development of Near-Infrared Fluorescent Probes for the in Vivo Brain Imaging of Amyloid-β Species in Alzheimer's Disease.

  2023cites this paper
• Copper binding and protein aggregation: a journey from the brain to the human lens

  2023cites this paper
• Bioinorganic Chemistry of Micronutrients Related to Alzheimer’s and Parkinson’s Diseases

  2023cites this paper
• Identification of hybrid amyloid strains assembled from amyloid-β and human islet amyloid polypeptide

  2023cites this paper
• Albumin-manganese dioxide nanocomposites: a potent inhibitor and ROS scavenger against Alzheimer's β-amyloid fibrillogenesis and neuroinflammation.

  2023cites this paper
• Molecular insights into the structure destabilization effects of ECG and EC on the Aβ protofilament: An all-atom molecular dynamics simulation study.

  2023cites this paper
• Aspartic Acid-Assisted Size-Controllable Synthesis of Nanoscale Spherical Covalent Organic Frameworks with Chiral Interfaces for Inhibiting Amyloid-β Fibrillation.

  2022cites this paper
• Persistent Endoplasmic Reticulum Stress Stimulated by Peptide Assemblies for Sensitizing Cancer Chemotherapy

  2022cites this paper
• Inhibition of Amyloid Protein Aggregation Using Selected Peptidomimetics

  2022cites this paper
• Engineering Nanointerfaces of Au25 Clusters for Chaperone-Mediated Peptide Amyloidosis.

  2022cites this paper
• Inhibition of p53 protein aggregation as a cancer treatment strategy.

  2022cites this paper
• Mechanistic insight into functionally different human islet polypeptide (hIAPP) amyloid: the intrinsic role of the C-terminal structural motifs.

  2022cites this paper
• Recent Advances in the Discovery of Therapeutics to Curtail Islet Amyloid Polypeptide Aggregation for Type 2 Diabetes Treatment

  2022cites this paper
• A role for bioinorganic chemistry in the reactivation of mutant p53 in cancer

  2022cites this paper
• Monosialotetrahexosylganglioside Promotes Early Aβ42 Oligomer Formation and Maintenance.

  2022cites this paper
• Molecular insights into the very early steps of Aβ1-42 pentameric protofibril disassembly by PGG: A molecular dynamics simulation study

  2022cites this paper
• APOE in the bullseye of neurodegenerative diseases: impact of the APOE genotype in Alzheimer’s disease pathology and brain diseases

  2022cites this paper
• The folding and misfolding mechanisms of multidomain proteins

  2022cites this paper
• Rational design of photoactivatable metal complexes to target and modulate amyloid-β peptides.

  2022cites this paper
• Linking Alzheimer’s Disease and Type 2 Diabetes: Characterization and Inhibition of Cytotoxic Aβ and IAPP Hetero-Aggregates

  2022cites this paper
• Peptide–Protein Interactions: From Drug Design to Supramolecular Biomaterials

  2021cites this paper
• The nickel-chelator dimethylglyoxime inhibits human amyloid beta peptide in vitro aggregation

  2021cites this paper
• Metallobiology and therapeutic chelation of biometals (copper, zinc and iron) in Alzheimer's disease: Limitations, and current and future perspectives.

  2021cites this paper
• Non-conventional photoactive transition metal complexes that mediated sensing and inhibition of amyloidogenic aggregates

  2021cites this paper
• Simultaneous spatial, conformational, and mass analysis of intact proteins and protein assemblies by nano-DESI travelling wave ion mobility mass spectrometry imaging

  2021cites this paper
• Probing molecular vibrations by monochromated electron microscopy

  2021cites this paper
• Characterization of copper(II) specific pyridine containing ligands: Potential metallophores for Alzheimer's disease therapy.

  2021cites this paper
• Inactivation of seeding activity of amyloid β‐protein aggregates in vitro

  2021cites this paper
• Exploring ensemble structures of Alzheimer’s amyloid β (1-42) monomer using linear regression for the MD simulation and NMR chemical shift

  2021cites this paper
• GM1 mediates the formation and maintenance of cytotoxic Aβ oligomers

  2021cites this paper
• Redox Properties of Small Molecules Essential for Multiple Reactivities with Pathological Factors in Alzheimer's Disease

  2021cites this paper
• Self-Assembled Nanochaperones Inhibit the Aggregation of Human Islet Amyloid Polypeptide Associated with Type 2 Diabetes.

  2021cites this paper
• Nanomaterials in Alzheimer's disease treatment: a comprehensive review.

  2021cites this paper
• Impact of sphingosine and acetylsphingosines on the aggregation and toxicity of metal-free and metal-treated amyloid-β

  2020cites this paper
• Molecular dynamics study on the effect of lipid membrane mechanical properties on the interaction between β-amyloid and lipid membrane

  2020cites this paper
• A comparison of the location in membranes of curcumin and curcumin-derived bivalent compounds with potential neuroprotective capacity for Alzheimer's disease.

  2020cites this paper
• Molecular insights into the inhibitory mechanisms of gallate moiety on the Aβ1-40 amyloid aggregation: A molecular dynamics simulation study.

  2020cites this paper
• Reactivity of Flavonoids Containing a Catechol or Pyrogallol Moiety with Metal‐Free and Metal‐Associated Amyloid‐β

  2020cites this paper
• Amyloid cross-seeding between Aβ and hIAPP in relation to the pathogenesis of Alzheimer and type 2 diabetes

  2020cites this paper
• Amyloid β-peptide interaction with GM1 containing model membrane

  2020cites this paper
• Neurotoxicity of different amyloid beta subspecies in mice and their interaction with isoflurane anaesthesia

  2020cites this paper
• Green tea extract EGCG plays a dual role in Aβ42 protofibril disruption and membrane protection: a molecular dynamic study.

  2020cites this paper
• Studies on the cross-interaction between hIAPP and Aβ25-35 and the aggregation process in binary mixture by electrospray ionization-ion mobility-mass spectrometry.

  2020cites this paper
• Effects of natural compounds on conformational properties and hairpin formation of amyloid-β42 monomer: docking and molecular dynamics simulation study

  2020cites this paper
• Deciphering the structural preference encoded in amide-I vibrations of lysine dipeptide in gas phase and in aqueous solution.

  2020cites this paper
• Identification of N-phenyl-3-methoxy-4-pyridinones as orally bioavailable H3 receptor antagonists and β-amyloid aggregation inhibitors for the treatment of Alzheimer's disease.

  2020cites this paper
• Natural Polyphenols as Modulators of the Fibrillization of Islet Amyloid Polypeptide.

  2020cites this paper
• Amentoflavone: A Bifunctional Metal Chelator that Controls the Formation of Neurotoxic Soluble Aβ42 Oligomers.

  2020cites this paper
• Biomimicked Biomaterials: Advances in Tissue Engineering and Regenerative Medicine

  2020cites this paper
• The Role of Glycation on the Aggregation Properties of IAPP

  2020cites this paper
• Understanding the Structure, Toxicity and Inhibition of IAPP at the Nanoscale

  2020cites this paper
• Application of mass spectrometry based proteomics to understand diabetes: A special focus on interactomics.

  2020cites this paper
• Lipid Modulation in the Formation of β-Sheet Structures. Implications for De Novo Design of Human Islet Amyloid Polypeptide and the Impact on β-Cell Homeostasis

  2020influential citation
• High-resolution probing of early events in amyloid-β aggregation related to Alzheimer's disease.

  2020cites this paper
• Curcumin: A review on neuroprotection

  2020cites this paper
• Emerging Role of TRIM Family Proteins in Cardiovascular Disease

  2020cites this paper
• The Investigation of Dissociation Mechanism of Single Walled Carbon Nanotube on Mature Amyloid-β Fibrils at Single Nanotube Level.

  2020cites this paper
• Advances in protein misfolding, amyloidosis and its correlation with human diseases

  2020cites this paper
• Medin Oligomer Membrane Pore Formation: A Potential Mechanism of Vascular Dysfunction

  2020cites this paper
• His18 promotes reactive oxidative stress production in copper-ion mediated human islet amyloid polypeptide aggregation

  2020cites this paper
• Acidic Environment Significantly Alters Aggregation Pathway of Human Islet Amyloid Polypeptide at Negative Lipid Membrane.

  2020cites this paper
• Elongation Factor-Tu switch I is a gate for aminoacyl-tRNA selection.

  2020cites this paper
• Ginnalin A Inhibits Aggregation, Reverses Fibrillogenesis and Alleviates Cytotoxicity of Amyloid β(1-42).

  2020cites this paper